Great. Thanks, everyone, for joining. My name is Scott Schoenhaus. I am the health care tech equity analyst here at KeyBanc. We're a pleasure to have Ben Taylor, CFO of Recursion for a fireside chat.

Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

Pine cones. Stock-market quotations. Sunflowers. Classical architecture. Reproduction of bees. Roman poetry. What do they have in common? In one way or another, these and many more creations of nature ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Test what you know about multiple intelligences. One of the most appealing ideas in psychology is the theory, first put forth by Harvard psychologist Howard Gardner in 1983, that several distinct ...

There’s nothing wrong with opening multiple brokerage accounts. In fact, it may be beneficial. Many, or all, of the products featured on this page are from our advertising partners who compensate us ...

Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Yarilet Perez is an experienced multimedia journalist and fact-checker with a Master of ...

Vaccines have changed modern medicine, leading to a 99 percent decline in the incidence of more than a dozen potentially deadly diseases. And the innovations keep coming. Now, in addition to a yearly ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...